• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人血浆前激肽释放酶。关于其被活化因子XII激活以及被二异丙基氟磷酸酯灭活的研究。

Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate.

作者信息

Bouma B N, Miles L A, Beretta G, Griffin J H

出版信息

Biochemistry. 1980 Mar 18;19(6):1151-60. doi: 10.1021/bi00547a018.

DOI:10.1021/bi00547a018
PMID:6768384
Abstract

Human plasma prekallikrein was purified from normal plasma. The purified prekallikrein appeared homogeneous on polyacrylamide gels in the presence of sodium dodecyl sulfate and mercaptoethanol and gave two protein bands with approximate Mr 85 000. Proteolytic activation of prekallikrein by purified human beta-factor XIIa (Mr 28 000 form) resulted in the formation of kallikrein. The apparent molecular weight of kallikrein determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis in the absence of mercaptoethanol was identical with that of prekallikrein; reduction of kallikrein yielded a heavy chain of Mr 52 000 and two light chains of Mr 42 000 and 37 000. The appearance of kallikrein activity was directly correlated with the limited proteolysis due to beta-factor XIIa. Kinetic and immunologic studies demonstrated that plasma prekallikrein is a factor XII dependent plasminogen proactivator. The rate constant for the inactivation of prekallikrein by diisopropyl phosphofluoridate was similar to that previously reported for trypsinogen. This observation raises the possibility that low intrinsinc catalytic activity of prekallikrein may play a role in the initiation of the intrinsic blood coagulation pathway.

摘要

人血浆前激肽释放酶从正常血浆中纯化得到。在十二烷基硫酸钠和巯基乙醇存在的情况下,纯化的前激肽释放酶在聚丙烯酰胺凝胶上呈现均一性,并给出两条分子量约为85000的蛋白带。纯化的人β-因子XIIa(分子量28000的形式)对前激肽释放酶的蛋白水解激活导致激肽释放酶的形成。在不存在巯基乙醇的情况下,通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳测定的激肽释放酶的表观分子量与前激肽释放酶相同;激肽释放酶的还原产生一条分子量52000的重链和两条分子量42000和37000的轻链。激肽释放酶活性的出现与β-因子XIIa引起的有限蛋白水解直接相关。动力学和免疫学研究表明,血浆前激肽释放酶是一种依赖因子XII的纤溶酶原激活剂。二异丙基氟磷酸酯使前激肽释放酶失活的速率常数与先前报道的胰蛋白酶原的速率常数相似。这一观察结果增加了前激肽释放酶低内在催化活性可能在凝血内源性途径启动中起作用的可能性。

相似文献

1
Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate.人血浆前激肽释放酶。关于其被活化因子XII激活以及被二异丙基氟磷酸酯灭活的研究。
Biochemistry. 1980 Mar 18;19(6):1151-60. doi: 10.1021/bi00547a018.
2
Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis.哈格曼因子底物。人血浆前激肽释放酶:哈格曼因子的激活机制及参与哈格曼因子依赖性纤维蛋白溶解作用。
J Biol Chem. 1977 Sep 10;252(17):6097-104.
3
Purification of guinea-pig plasma prekallikrein. Activation by prekallikrein activator derived from guinea-pig skin.豚鼠血浆前激肽释放酶的纯化。源自豚鼠皮肤的前激肽释放酶激活剂对其的激活作用。
Biochim Biophys Acta. 1980 Aug 7;614(2):511-25. doi: 10.1016/0005-2744(80)90240-5.
4
The contact activation mechanism in human plasma: activation induced by dextran sulfate.人血浆中的接触激活机制:硫酸葡聚糖诱导的激活。
Blood. 1982 Jun;59(6):1225-33.
5
Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.表面介导的牛因子XII和前激肽释放酶激活的动力学研究。高岭土和高分子量激肽原对激活反应的影响。
Eur J Biochem. 1985 Jan 2;146(1):43-50. doi: 10.1111/j.1432-1033.1985.tb08617.x.
6
Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator.因子 XII 依赖的纤维蛋白溶解:血浆激肽释放酶的双重功能以及一种先前未描述的因子 XII 和激肽释放酶依赖的纤溶酶原激活剂的出现。
Thromb Haemost. 1979 Jun 30;41(4):756-73.
7
Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein.在没有激肽释放酶的情况下,通过Hageman因子的作用从高分子量激肽原释放激肽。
J Biol Chem. 1983 Jul 25;258(14):8963-70.
8
Reduced or unchanged cofactor function of human high molecular weight kininogen induced by human plasma kallikrein.人血浆激肽释放酶诱导的人高分子量激肽原的辅因子功能降低或不变。
Adv Exp Med Biol. 1986;198 Pt A:147-53. doi: 10.1007/978-1-4684-5143-6_20.
9
Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.表面介导的牛因子XII和前激肽释放酶激活机制。
Adv Exp Med Biol. 1983;156:87-107.
10
Deficiency of factor XII-dependent plasminogen proactivator in prekallikrein-deficient plasma.前激肽释放酶缺乏血浆中依赖因子XII的纤溶酶原激活剂缺乏。
J Lab Clin Med. 1978 Jan;91(1):148-55.

引用本文的文献

1
Bradykinin formation. Plasma and tissue pathways and cellular interactions.缓激肽的形成。血浆和组织途径以及细胞相互作用。
Clin Rev Allergy Immunol. 1998 Winter;16(4):403-29. doi: 10.1007/BF02737659.
2
Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway.牙周炎的发病机制:牙龈卟啉单胞菌的一种主要精氨酸特异性半胱氨酸蛋白酶通过激活激肽释放酶/激肽途径诱导血管通透性增强。
J Clin Invest. 1994 Jul;94(1):361-7. doi: 10.1172/JCI117330.
3
Purification and characterization of two functionally distinct forms of C1 inhibitor from a patient with angioedema.
从一名血管性水肿患者中纯化和鉴定两种功能不同形式的C1抑制剂。
Clin Exp Immunol. 1981 Aug;45(2):261-70.
4
The activation of the alternative pathway C3 convertase by human plasma kallikrein.人血浆激肽释放酶对替代途径C3转化酶的激活作用。
Immunology. 1982 Mar;45(3):587-95.
5
Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI.血液凝固因子XIa特异性结合于活化的人血小板上与因子XI不同的位点。
J Clin Invest. 1984 Jun;73(6):1550-6. doi: 10.1172/JCI111361.
6
Rapid purification of a high-affinity plasminogen activator from human blood plasma by specific adsorption on fibrin/Celite.通过在纤维蛋白/硅藻土上特异性吸附从人血浆中快速纯化高亲和力纤溶酶原激活剂。
Proc Natl Acad Sci U S A. 1981 Jul;78(7):4265-9. doi: 10.1073/pnas.78.7.4265.
7
Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease.联合因子V/ VIII缺乏症中蛋白C抑制剂缺乏
J Clin Invest. 1980 Nov;66(5):1186-9. doi: 10.1172/JCI109952.
8
Inactivation of kallikrein in human plasma.人血浆中激肽释放酶的失活
J Clin Invest. 1983 Jan;71(1):149-58. doi: 10.1172/jci110743.
9
Characterization of a variant prekallikrein, prekallikrein Long Beach, from a family with mixed cross-reacting material-positive and cross-reacting material-negative prekallikrein deficiency.来自一个既有混合交叉反应物质阳性又有交叉反应物质阴性前激肽释放酶缺乏症的家族的一种变异型前激肽释放酶——长滩前激肽释放酶的特征分析。
J Clin Invest. 1986 Jul;78(1):170-6. doi: 10.1172/JCI112547.
10
Experimental pulmonary inflammatory injury in the monkey.猴子的实验性肺炎性损伤
J Clin Invest. 1985 Sep;76(3):1182-92. doi: 10.1172/JCI112074.